RankingsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Total assets

RaQualia Pharma Inc.【JP:4579】

Market cap
¥22.3B
P/E ratio
-313.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Dec 31, 20249,655+40.51%
Dec 31, 20236,872+9.82%
Dec 31, 20226,258+19.55%
Dec 31, 20215,234+23.12%
Dec 31, 20204,251-12.10%
Dec 31, 20194,837+19.35%
Dec 31, 20184,052-19.98%
Dec 31, 20175,064+26.00%
Dec 31, 20164,019-15.42%
Dec 31, 20154,752-8.65%
Dec 31, 20145,202

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)